Evaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered Concurrently to Subjects With Various Degrees of Renal Impairment and Healthy Matched Control Subjects
Clinical trial NCT03310463 · COMPLETED
Trial details
- NCT number
- NCT03310463
- Sponsor
- Entasis Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-03
- Primary completion
- 2018-05-25
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.